A commons-based approach opens new doors to scientific discovery. The publications below represent the collective efforts of PCDC disease consortia. For a more detailed view into the planned, ongoing, and published research of PCDC consortia, see our PCDC research dashboard.
In addition, Data for the Common Good has published numerous papers about our methods and the potential applications of data sharing in pediatric cancer research; you can read more about those publications here.
Click each consortium name to expand the list of publications.
Additional INRG publications and INRG Task Force consensus papers preceding the launch of the data commons may be found on the INRG website.
Vieira AGS, Puthenpura V, Krailo M, et al. Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium. Pediatr Blood Cancer. 2023 Aug;70(8):e30426.
Lafin JT, Scarpini CG, Amini A, et al. Refining the serum miR-371a-3p test for viable germ cell tumor detection. Sci Rep. 2023 Jun 29;13(1):10558.
Xu L, Pierce JL, Sanchez A, et al. Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. Nat Commun. 2023 May 6;14(1):2636.
Konneh B, Lafin JT, Howard J, et al. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection. Andrology. 2023 May;11(4):634-640
Additional MaGIC publications preceding their partnership with the PCDC may be found on their website.